Dewi Nikmah Utami, Boshuizen Hendriek C, Johansson Mattias, Vineis Paolo, Kampman Ellen, Steffen Annika, Tjønneland Anne, Halkjær Jytte, Overvad Kim, Severi Gianluca, Fagherazzi Guy, Boutron-Ruault Marie-Christine, Kaaks Rudolf, Li Kuanrong, Boeing Heiner, Trichopoulou Antonia, Bamia Christina, Klinaki Eleni, Tumino Rosario, Palli Domenico, Mattiello Amalia, Tagliabue Giovanna, Peeters Petra H, Vermeulen Roel, Weiderpass Elisabete, Torhild Gram Inger, Huerta José María, Agudo Antonio, Sánchez María-José, Ardanaz Eva, Dorronsoro Miren, Quirós José Ramón, Sonestedt Emily, Johansson Mikael, Grankvist Kjell, Key Tim, Khaw Kay-Tee, Wareham Nick, Cross Amanda J, Norat Teresa, Riboli Elio, Fanidi Anouar, Muller David, Bueno-de-Mesquita H Bas
Am J Epidemiol. 2016 Jul 15;184(2):129-39. doi: 10.1093/aje/kwv298. Epub 2016 Jul 1.
The associations of body mass index (BMI) and other anthropometric measurements with lung cancer were examined in 348,108 participants in the European Investigation Into Cancer and Nutrition (EPIC) between 1992 and 2010. The study population included 2,400 case patients with incident lung cancer, and the average length of follow-up was 11 years. Hazard ratios were calculated using Cox proportional hazard models in which we modeled smoking variables with cubic splines. Overall, there was a significant inverse association between BMI (weight (kg)/height (m)(2)) and the risk of lung cancer after adjustment for smoking and other confounders (for BMI of 30.0-34.9 versus 18.5-25.0, hazard ratio = 0.72, 95% confidence interval: 0.62, 0.84). The strength of the association declined with increasing follow-up time. Conversely, after adjustment for BMI, waist circumference and waist-to-height ratio were significantly positively associated with lung cancer risk (for the highest category of waist circumference vs. the lowest, hazard ratio = 1.25, 95% confidence interval: 1.05, 1.50). Given the decline of the inverse association between BMI and lung cancer over time, the association is likely at least partly due to weight loss resulting from preclinical lung cancer that was present at baseline. Residual confounding by smoking could also have influenced our findings.
在1992年至2010年期间,对欧洲癌症与营养调查(EPIC)中的348,108名参与者进行了体重指数(BMI)及其他人体测量指标与肺癌之间关联的研究。研究人群包括2400例新发肺癌患者,平均随访时间为11年。使用Cox比例风险模型计算风险比,其中我们用三次样条函数对吸烟变量进行建模。总体而言,在对吸烟及其他混杂因素进行调整后,BMI(体重(千克)/身高(米)²)与肺癌风险之间存在显著的负相关(BMI为30.0 - 34.9与18.5 - 25.0相比,风险比 = 0.72,95%置信区间:0.62, 0.84)。随着随访时间的增加,这种关联的强度下降。相反,在对BMI进行调整后,腰围和腰高比与肺癌风险显著正相关(腰围最高类别与最低类别相比,风险比 = 1.25,95%置信区间:1.05, 1.50)。鉴于BMI与肺癌之间的负相关随时间下降,这种关联可能至少部分归因于基线时存在的临床前期肺癌导致的体重减轻。吸烟造成的残余混杂因素也可能影响了我们的研究结果。